Joint Annual Meeting ISMRM-ESMRMB 2014 10-16 May 2014 Milan, Italy

Quantitative Biomarkers of Diffuse Liver Disease
SKILL LEVEL: Intermediate to Advanced
ORGANIZERS: John P. Mugler, III, Ph.D., Ivan Pedrosa, M.D., Scott B. Reeder, M.D., Ph.D., & Shreyas S. Vasanawala, M.D., Ph.D.
Monday, 12 May 2014
This two-hour course focuses on the role of MRI methods as quantitative biomarkers of diffuse liver disease. Emerging quantitative methods for detection and staging of important features of diffuse liver disease, including steatosis, iron overload, fibrosis, hepatocyte function and hemodynamics will be reviewed by leading experts. All presentations feature didactic–interactive lectures using audience response technology.
This course is aimed at clinicians, imaging scientists and MR technologists interested in diffuse liver disease and emerging quantitative MRI biomarkers used for improved diagnosis and disease staging.

As a result of attending this course, participants should be able to:

  • Classify the basic clinical features of diffuse liver disease;
  • Incorporate the main strategies for quantifying fat, iron, fibrosis, hepatocyte function and hemodynamics with MRI; and
  • Appropriately utilize these biomarkers in assessment of diffuse liver disease.


Moderator: Claude B. Sirlin, M.D.

16:00 Fat & Iron Claude B. Sirlin, M.D.
16:30 Fibrosis: Elastography & DWI Sudhakar K. Venkatesh, M.D., FRCPR
17:00 Contrast Enhanced Functional Imaging of the Liver Eduard Jonas, Ph.D.
17:30 Flow Quantification in Portal Hypertension Zoran Stankovic, M.D.
18:00     Adjournment